Eden’s journey with IMFINZI® (durvalumab)

(4:4)

Durvalumab - Imfinzi - All You Need to Know in 2 Minutes.

(2:49)

Immunotherapy Nightmare - Imfinzi/Durvalumab Experience - Lung Cancer

(52:55)

Mickey and his caregiver, Carla, talk about IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl)

(9:10)

Case Based Panel Discussion - Stage 3 NSCLC Best Schedule - Durvalumab/Imfinzi in Varying Patients

(8:16)

Dr. Simon on Durvalumab for Patients With Lung Cancer

(1:20)

Durvalumab following chemoradiotherapy improves survival in patients with limited-stage small-ce...

(4:33)

Durvalumab (Imfinzi): How It Works, Benefits, and Side Effects Explained

(2:15)

Dr. Langer on the Benefit of Durvalumab in Stage III NSCLC

(2:10)

Durvalumab ( Imfinzi ) for HCC

(6:29)

Imfinzi Uses: Guide to Understanding the Many Benefits of this Breakthrough Immunotherapy

(8:28)

OncTalk 2021 - PDL1 and Imfinzi/Durvalumab

(7:45)

Dr. Feldman on Durvalumab for Patients With Lung Cancer

(47)

Keytruda, Immunotherapy Drug That Aided Jimmy Carter’s Cancer, ‘A Huge Deal’ | TODAY

(2:31)

'Miracle' drug Dostarlimab gives astonishing results as cancer vanishes from 12 people

(2:49)

FDA Approves Durvalumab / Imfinzi for Resectable NSCLC Non-Small Cell Lung Cancer

(2:43)

FDA Approval of Durvalumab for Stage III Unresectable NSCLC

(1:36)

FDA D.I.S.C.O. Burst Edition: FDA approval of Imfinzi (durvalumab) for adult patients with locall...

(3:31)

Durvalumab addtion to chemo shows endometrial cancer benefit

(4:31)

Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of Care? (BMIC-024)

(7:44)

NIAGARA: perioperative durvalumab with neoadjuvant chemotherapy in MIBC

(2:26)

Durvalumab after chemoradiotherapy improves overall survival in lung cancer patients

(2:56)